As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.

Genetically targeted technologies can improve heart disease treatment, but only with legislation that supports continued research and development.

The surgery is an open-heart procedure where a surgeon uses part of a blood vessel from somewhere else in your body to ...

Coronary artery disease (CAD) continues to be a leading cause of morbidity and mortality globally. The recommendations that ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...